Skip to main content

letter

. 1983 Jul 30;287(6388):363–364. doi: 10.1136/bmj.287.6388.363-c

Antiemetics and cytotoxic drugs.

M G Kris, R J Gralla, L B Tyson, R A Clark

PMCID: PMC1548554 PMID: 6409310

363

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Daniels M., Belt R. J. High dose metoclopramide as an antiemetic for patients receiving chemotherapy with cis-platinum. Oncol Nurs Forum. 1982 Summer;9(3):20–22. [PubMed] [Google Scholar]
Gralla R. J., Itri L. M., Pisko S. E., Squillante A. E., Kelsen D. P., Braun D. W., Jr, Bordin L. A., Braun T. J., Young C. W. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med. 1981 Oct 15;305(16):905–909. doi: 10.1056/NEJM198110153051601. [DOI] [PubMed] [Google Scholar]
Peroutka S. J., Snyder S. H. Antiemetics: neurotransmitter receptor binding predicts therapeutic actions. Lancet. 1982 Mar 20;1(8273):658–659. doi: 10.1016/s0140-6736(82)92206-1. [DOI] [PubMed] [Google Scholar]
Strum S. B., McDermed J. E., Opfell R. W., Riech L. P. Intravenous metoclopramide. An effective antiemetic in cancer chemotherapy. JAMA. 1982 May 21;247(19):2683–2686. doi: 10.1001/jama.247.19.2683. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES